Relation of the "Hypertriglyceridemic Waist" Phenotype to Earlier Manifestations of Coronary Artery Disease in Patients With Glucose Intolerance and Type 2 Diabetes Mellitus

American Journal of Cardiology

Volumn 99, Issue 3, 2007, Pages 369-373

  St Pierre, Julie ^a,b   Lemieux, Isabelle ^b   Perron, Patrice ^a,c   Brisson, Diane ^a   Santuré, Marta ^a   Vohl, Marie Claude ^d   Després, Jean Pierre ^b,d   Gaudet, Daniel ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITÉ DE SHERBROOKE   (Canada)

^d UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; GLUCOSE; HEMOGLOBIN A1C; INSULIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CONCENTRATION RESPONSE; CORONARY ARTERY DISEASE; DISEASE MARKER; EARLY DIAGNOSIS; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HUMAN; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIC WAIST; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GLUCOSE INTOLERANCE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTRIGLYCERIDEMIA; MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; PHENOTYPE; PROGNOSIS; RISK FACTORS; TIME FACTORS; TRIGLYCERIDES;

EID: 33846555705     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.08.041     Document Type: Article

References (29)

1. Mokdad A.H., Bowman B.A., Ford E.S., Vinicor F., Marks J.S., and Koplan J.P. The continuing epidemics of obesity and diabetes in the United States. JAMA 286 (2001) 1195-1200
2. Mokdad A.H., Serdula M.K., Dietz W.H., Bowman B.A., Marks J.S., and Koplan J.P. The spread of the obesity epidemic in the United States, 1991-1998. JAMA 282 (1999) 1519-1522
3. Zimmet P., Shaw J., Murray S., and Sicree R. The diabetes epidemic in full flight: forecasting the future. Diabetes Voice 48 (2003) 12-16
4. Grundy S.M., Benjamin E.J., Burke G.L., Chait A., Eckel R.H., Howard B.V., Mitch W., Smith Jr. S.C., and Sowers J.R. Diabetes and cardiovascular disease. A statement for healthcare professionals from the American Heart Association. Circulation 100 (1999) 1134-1146
5. Lee W.L., Cheung A.M., Cape D., and Zinman B. Impact of diabetes on coronary artery disease in women and men. Diabetes Care 23 (2000) 962-968
6. Qiao Q., Jousilahti P., Eriksson J., and Tuomilehto J. Predictive properties of impaired glucose tolerance for cardiovascular risk are not explained by the development of overt diabetes during follow-up. Diabetes Care 26 (2003) 2910-2914
7. Lamarche B., Tchernof A., Mauriège P., Cantin B., Dagenais G.R., Lupien P.J., and Despres J.P. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA 279 (1998) 1955-1961
8. Lemieux I., Pascot A., Couillard C., Lamarche B., Tchernof A., Alméras N., Bergeron J., Gaudet D., Tremblay G., Prud'homme D., Nadeau A., and Despres J.P. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia, hyperapolipoprotein B, small, dense LDL) in men?. Circulation 102 (2000) 179-184
9. St-Pierre J., Lemieux I., Vohl M.C., Perron P., Tremblay G., Després J.P., and Gaudet D. Contribution of abdominal obesity and hypertriglyceridemia to impaired fasting glucose and coronary artery disease. Am J Cardiol 90 (2002) 15-18
10. Gaudet D., Tremblay G., Perron P., Gagne C., Ouadahi Y., and Moorjani S. Familial hypercholesterolemia in eastern Quebec: a public health problem?. The experience of the Hyperlipidemia Clinic of Chicoutimi. Union Med Can 124 (1995) 54-60
11. Richterich R., and Dauwalder H. Zur Bestimmung der Plasmaglukosekonzentration mit der Hexokinase-Glucose-6-Phosphat-Dehydrogenase-Methode. Schweiz Med Wochenschr 101 (1971) 615-618
12. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 26 suppl 1 (2003) S33-S50
13. Alpert J.S., Thygesen K., Antman E., and Bassand J.P. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36 (2000) 959-969
14. Gaudet D., Vohl M.C., Perron P., Tremblay G., Gagné C., Lesiège D., Bergeron J., Moorjani S., and Despres J.P. Relationships of abdominal obesity and hyperinsulinemia to angiographically assessed coronary artery disease in men with known mutations in the LDL receptor gene. Circulation 97 (1998) 871-877
15. Gaudet D., Vohl M.C., Julien P., Tremblay G., Perron P., Gagné C., Bergeron J., Moorjani S., and Despres J.P. Relative contribution of low-density lipoprotein receptor and lipoprotein lipase gene mutations to angiographically assessed coronary artery disease among French Canadians. Am J Cardiol 82 (1998) 299-305
16. Burstein M., and Samaille J. Sur un dosage rapide du cholestérol lié aux β-lipoprotéines du sérum. Clin Chim Acta 5 (1960) 609
17. 2+ precipitation procedures for quantitation of high-density lipoprotein cholesterol. Clin Chem 28 (1982) 1379-1387
18. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
19. Laurell C.B. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Ann Biochem 15 (1966) 45-52
20. The Airlie (VA) Consensus Conference. In: Lohman T., Roche A., and Martorel R. (Eds). Standardization of Anthropometric Measurements (1988), Human Kinetics, Champaign, IL 39-80
21. NCEP Expert Panel. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
22. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15 (1998) 539-553
23. Snijder M.B., Dekker J.M., Visser M., Bouter L.M., Stehouwer C.D., Kostense P.J., Yudkin J.S., Heine R.J., Nijpels G., and Seidell J.C. Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn study. Am J Clin Nutr 77 (2003) 1192-1197
24. Tchernof A., Lamarche B., Prud'homme D., Nadeau A., Moorjani S., Labrie F., Lupien P.J., and Despres J.P. The dense LDL phenotype: association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men. Diabetes Care 19 (1996) 629-637
25. Lamarche B., Tchernof A., Moorjani S., Cantin B., Dagenais G.R., Lupien P.J., and Despres J.P. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study. Circulation 95 (1997) 69-75
26. Després J.P., Lamarche B., Mauriège P., Cantin B., Dagenais G.R., Moorjani S., and Lupien P.J. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334 (1996) 952-957
27. McNamara J.R., Jenner J.L., Li Z., Wilson P.W., and Schaefer E.J. Change in LDL particle size is associated with change in plasma triglyceride concentration. Arterioscler Thromb 12 (1992) 1284-1290
28. Laaksonen D.E., Lakka H.M., Niskanen L.K., Kaplan G.A., Salonen J.T., and Lakka T.A. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 156 (2002) 1070-1107
29. Razak F., Anand S., Vuksan V., Davis B., Jacobs R., Teo K.K., Yusuf S., and SHARE Investigators. Ethnic differences in the relationships between obesity and glucose-metabolic abnormalities: a cross-sectional population-based study. Int J Obes 29 (2005) 656-667